日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comprehensive characterization of VSIR reveals dual epigenetic regulation and immune landscape across hematological malignancies

对VSIR的全面表征揭示了血液系统恶性肿瘤中的双重表观遗传调控和免疫图谱

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-41978-2
Xu, Zi-Jun; Wu, Xiao-Mei; Chang, Ran; Cao, Hao-Yu; Wang, Fei; Wen, Xiang-Mei; Zhou, Jing-Dong; Lin, Jiang; Qian, Jun
肿瘤
表观遗传
肿瘤免疫
信号转导
免疫/内分泌
发表日期：2026
文献求助 收藏

A rare cytogenetically cryptic MECOM rearrangement in a patient with myelodysplastic neoplasm and SF3B1 mutation identified by RNA sequencing: a case report

一例罕见的细胞遗传学隐匿性MECOM重排在骨髓增生异常综合征患者中被发现，并通过RNA测序鉴定出SF3B1突变：病例报告

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1742267
Jin, Ye; Xu, Zi-Jun; Lv, Chao-Ran; Qian, Zhen; Wen, Xiang-Mei; Xiao, Sheng; Lin, Jiang; Qian, Jun
细胞生物学
SF3B1
发表日期：2026
文献求助 收藏

Molecular international prognostic index prognostic model in diffuse large B-cell lymphoma

弥漫性大B细胞淋巴瘤的分子国际预后指数预后模型

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-026-04817-4
Zhang, Ting-Juan; Wu, Xiao-Chi; Chu, Ming-Qiang; Xu, Zi-Jun; Qiao, Liang; Zhao, Yang-Jing; Qian, Jun; Zhou, Jing-Dong
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2026
文献求助 收藏

Identification and validation of HOXB3 hypomethylation as a novel prognostically epigenetic biomarker in acute myeloid leukemia

HOXB3 低甲基化作为急性髓系白血病中一种新型预后表观遗传生物标志物的鉴定和验证

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1709417
Zhang, Ting-Juan; Chang, Ran; Xie, Fei; Xu, Zi-Jun; Chu, Ming-Qiang; Wu, Xiao-Chi; Qian, Jun; Zhou, Jing-Dong
白血病
表观遗传
发表日期：2025
文献求助 收藏

Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity

生物信息学分析显示，血液系统恶性肿瘤中STING的表达与预后和抗肿瘤免疫相关。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1477100
Wen, Xiang-Mei; Xu, Zi-Jun; Ma, Ji-Chun; Zhang, Min-Jie; Jin, Ye; Lin, Jiang; Qian, Jun; Fang, Yuan-Yuan; Luo, Shu-Yu; Mao, Zhen-Wei
STING
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

FOXP1 is associated with oncogenesis and clinical outcomes in hematologic malignancies

FOXP1与血液系统恶性肿瘤的发生和临床结局相关

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1569641
Wen, Xiang-Mei; Xu, Zi-Jun; Ni, Hao-Xi; Liu, Su-Wan; Jin, Ye; Zhao, Wei; Luo, Shu-Yu; Fang, Yuan-Yuan; Mao, Zhen-Wei; Lin, Jiang; Qian, Jun
FOXP1
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia

HOXA9甲基化作为表观遗传生物标志物在急性髓系白血病预后预测和治疗选择指导中的应用

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-13633-y
Xie, Fei; Zhang, Ting-Juan; Zhang, Xin-Long; Xu, Zi-Jun; Qiao, Liang; Wang, Yun; Zhao, Yang-Jing; Qian, Jun; Zhou, Jing-Dong
白血病
表观遗传
发表日期：2025
文献求助 收藏

Overexpression and oncogenic role of RIPK3 in acute myeloid leukemia associated with specific subtypes and treatment outcome

RIPK3在急性髓系白血病中的过度表达及其致癌作用与特定亚型和治疗结果相关

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-13613-2
Wang, Yun; Zhang, Ting-Juan; Zhang, Liu-Chao; Xu, Zi-Jun; Chu, Ming-Qiang; Zhao, Yang-Jing; Lin, Jiang; Qian, Jun; Zhou, Jing-Dong
RIPK3
肿瘤
肿瘤免疫
白血病
RIP
发表日期：2025
文献求助 收藏

GFPT2 promotes paclitaxel resistance in epithelial ovarian cancer cells via activating NF-κB signaling pathway

GFPT2通过激活NF-κB信号通路促进上皮性卵巢癌细胞对紫杉醇的耐药性

期刊:Open Life Sciences
影响因子:1.7
doi:10.1515/biol-2022-1039
Xu, Zi-Jun; Liu, Bin; Li, Ruo-Nan; Linghu, Hua
肿瘤
肿瘤免疫
信号转导
NF-κB
GFP
卵巢癌
细胞生物学
发表日期：2025
文献求助 收藏

A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma

一种新型的蛋氨酸代谢相关特征可预测肺腺癌的预后和免疫治疗反应

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.204687
Chang, Qing-Hua; Zhang, Yuan-Cui; Zhang, Dong-Ying; Mao, Ting; Chang, Ran; Wang, Nan; Ye, Yun; Xu, Zi-Jun
免疫/内分泌
代谢
肿瘤免疫
肿瘤
发表日期：2023
文献求助 收藏